The ICE-T Congress is dedicated to fostering a strong and enduring Academic-Community partnership, one designed to cultivate mutual learning, provide meaningful support, and remove barriers to care while encouraging bold aspirations.
This initiative commenced in Kansas City, Kansas, in July 2024. Building upon that foundation, the first National ICE-T Congress was successfully convened in Orlando, Florida, in July 2025. Following this milestone, preparations are now underway for the second regional ICE-T Congress, scheduled to take place in Kansas City, Kansas, in September 2025. The mission of the ICE-T Congress extends beyond regional and national boundaries. Advocacy efforts are being advanced at every level, including internationally, with plans for a forthcoming congress outside the United States.
At its core, the ICE-T Congress is committed to representing and supporting every patient who has encountered obstacles in their pursuit of healing. By championing equitable access to ICE-T therapies, the initiative endeavors to inspire systemic change and bring renewed hope to individuals and communities most in need.
Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared some key highlights from Day 2 of ICE-T Congress:
ICE-T Congress Day 2 Kicks Off with Opening Remarks
“Kicking off Day 2 of the ICE-T Congress with opening remarks by Nausheen Ahmed andZahra Mahmoudjafari – ready for another day of innovation and collaboration.”
“A powerful start to Day 2 with Keynote Speaker Dr. Sayed Osman Ahmed (KFSHRC, the flagship tertiary hospital in the Middle East) presenting Global Experience with Cellular Therapeutics – aligning with our group’s GLAMM study.”
Marc Hoffmann kicks off ICE-T lymphoma panel on bispecifics in NHL
“Marc Hoffmann kicks off the Lymphoma Discussion on Bispecifics in NHL at the ICE-T Congress – advancing innovation in lymphoma care.”
Dr. Sayeef Mirza on CAR-T advances in lymphoma at ICE-T
“Dr. Sayeef Mirza presenting Advances in CAR-T Therapies for Lymphoma at the ICE-T Congress – pushing the frontier of lymphoma care.”
Panel on sequencing therapies in lymphoma
“Now panel discussion on sequencing therapies in Lymphoma! Led by Zahra M with insights from Dr. Sayeef Mirza, Dr. Furha Crossor, Dr. Abdulraheem Qasem and Jayda Esplund PharmD.”
“Day 2 I-CET Congress Session 7 Workshops.
Toxicity Management led by Moderator Allison Appenfeller with Muhammad Nashatizadeh. Panel on Late Neurotoxicity (MNT) featuring Nahid Suleman, Maggie Nelson and Rachel Sigel.”
ICE-T Congress Leukemias and MDS session
“Leukemias and MDS session at I CET Congress! Moderator: Al-Ola Abdallah Jesus Gonzalez-Lugo – Cellular Therapies in ALL Abdulraheem Yacoub – Cellular Therapies in Myeloid Malignancies Innovations shaping the future of blood cancer care.”
Gene Therapy Spotlight at I-CET Congress
“Gene Therapy spotlight at ICET Congress! Moderator: Mindy Allen Panelists: Rajat Bansal, Robert Kribs, Anuj Shreshtha, Shelby Hawkins and Natalie Eberle Exploring breakthroughs bringing gene therapy closer to patients!”
Next stop: Charlotte, NC, April 18, 2025 for National I-CET Congress
“See you all in Charlotte, NC for our next National I-CET Congress in April 18 2025! Special thanks to Shebli Atrash and Dr. Barry Paul for chairing this incredible event.”
More from Al-Ola Abdallah on OncoDaily.